Yep this is an awesome announcement. Surely it's worth being...

Yep this is an awesome announcement. Surely it's worth being designated as MARKET SENSITIVE when the announcement is about a liquid form of their existing proven and safe drug being used to treat Blood Pressure, as an Anti-Inflammatory, and basically entering new fields of medicine which have markets of Tens of Millions of patients around the world! This is exciting stuff and shows Wolgen is about building this company into a major Healthcare company with multiple indications and revenue streams. It's not about licensing out tech and making a quick buck, but building real long term shareholder value and bringing new medicines to new patients, some of whom have never had treatment before.